• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PERIMOUNT MAGNA PERICARDIAL BIOPROSTHESIS; REPLACEMENT HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PERIMOUNT MAGNA PERICARDIAL BIOPROSTHESIS; REPLACEMENT HEART VALVE Back to Search Results
Model Number 3000TFX
Device Problems Perivalvular Leak (1457); Inadequacy of Device Shape and/or Size (1583)
Patient Problems Aortic Insufficiency (1715); Aortic Valve Stenosis (1717); Calcium Deposits/Calcification (1758); Death (1802); Mitral Regurgitation (1964)
Event Date 12/13/2018
Event Type  Death  
Manufacturer Narrative
Regurgitation is considered to be a perivalvular leak (pvl) if a turbulent eccentric jet originates between the bioprosthetic sewing ring and the annulus.There are technique and anatomical related factors that can contribute to the development of pvl.In this case, it was noted that the valve was well-seated.There was no valvular damage or perivalvular gaps seen.There was no clear area of leak.The root cause of this event cannot be determined with the available information.The device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.There were no issues identified that would have impacted this event.Edwards lifesciences will continue to monitor all reported events.No further actions are required at this time.(b)(4).Please reference mfr report #2015691-2019-00523 for the 27mm edwards valve also used in this case.
 
Event Description
Edwards lifesciences maintains an implant patient registry.This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital and patient family members) and is not received in the form of a conventional "customer complaint." the information reported may or may not be related to the edwards device.In this case, it was learned that a 3000tfx 27mm aortic valve was explanted at implant due to perivalvular leak secondary to sizing issues.Per the operative report, this patient presented with significant aortic stenosis and minimal mitral regurgitation with an ef of 44%.Initially, redo-cabg x2 was performed.During the avr, the native aortic valve was trileaflet with a heavily calcified annulus.The valve was implanted and noted to be well-seated; however, echo revealed a significant perivalvular leak.Severe wide open mitral regurgitation was also noted.The patient was placed back on bypass and the valve was examined.There was no valvular damage and no perivalvular gaps seen.Despite finding no clear area of leak, the valve was explanted and new sutures were placed.A 3000tfx 25mm valve (subject device) was placed with no obvious technical issues.However, re-pressurizing the root resulted in identical echo findings.The cause of the perivalvular leak could not be identified.Cardiopulmonary bypass was eventually discontinued after an iabp was placed, which transiently improved the mitral regurgitation and lv function.A continued decompensation with progressive lactic acidosis was documented.This was with maximal inotropic support, no inhalation and iabp.After consolation, the family wished to avoid another bypass run or ecmo.Pacing was discontinued and the patient was declared dead.
 
Manufacturer Narrative
Corrected data: f10, h6.Reference capa-20-00141.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARPENTIER-EDWARDS PERIMOUNT MAGNA PERICARDIAL BIOPROSTHESIS
Type of Device
REPLACEMENT HEART VALVE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
MDR Report Key8346284
MDR Text Key136443522
Report Number2015691-2019-00524
Device Sequence Number1
Product Code DYE
Combination Product (y/n)N
PMA/PMN Number
P860057/S022
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other
Type of Report Initial,Followup
Report Date 01/24/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/15/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/23/2022
Device Model Number3000TFX
Was Device Available for Evaluation? No
Date Manufacturer Received07/23/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death; Required Intervention;
Patient Age70 YR
Patient Weight91
-
-